Floatz logo

Irinotecan

Fever

AmgenSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Fever cohort.

Asset / SponsorPhaseRating
PEGFILGRASTIM
Amgen
Phase 3BB
Cytosin-Arabinosid
Amgen
Phase 3BB
Daunorubicin
Amgen
Phase 3BB
(+)-VINCRISTINE
Amgen
Phase 3B
Gm-Csf
National Cancer Institute (NCI)
Phase 3B

View all 18 →

Same molecule, other indications

Irinotecan is also rated in:

rectal cancerDormant
BBB
Indicative ·
78 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Peritoneal NeoplasmsDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →